Analytical Data
-
基因名
MUCL1
-
简介
The MUCL1 protein has the potential to serve as a diagnostic marker for metastatic breast cancer, providing utility in identifying and characterizing this disease stage. It can serve as a molecular marker to aid diagnosis and evaluation and have an impact on treatment planning and prognosis. MUCL1 Protein, Human (HEK293, His) is the recombinant human-derived MUCL1 protein, expressed by HEK293 , with C-His labeled tag.
- Application
-
别名
Mucin-like protein 1; Protein BS106; Small breast epithelial mucin; SBEM
-
种属
Human
-
表达系统
HEK293
-
标签
C-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q96DR8
-
表达区间
N21-P90
-
蛋白长度
Full Length of Mature Protein
-
分子量
20-30 kDa due to glycosylation
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MUCL1 (Mucin-Like 1) is a type of membrane-bound glycoprotein that belongs to the mucin family, which plays critical roles in cellular signaling, adhesion, and immune response. The research surrounding MUCL1 has intensified due to its potential implications in various diseases, particularly in cancer, inflammation, and infectious diseases. Studies suggest that MUCL1 may be involved in tumor progression and metastasis, making it a promising target for therapeutic interventions. Its expression patterns have been shown to vary significantly in different tissues and under distinct pathological conditions, hinting at its regulatory roles in cell behavior and interaction with the microenvironment. The production of recombinant MUCL1 protein is essential for these studies, as it allows researchers to investigate its structural and functional properties, including its interaction with other biomolecules. By utilizing recombinant techniques, scientists can produce MUCL1 in controlled environments, facilitating the exploration of its biological functions, the development of specific antibodies, and the assessment of its therapeutic potential in modulating immune responses. Understanding the biochemical and functional characteristics of MUCL1 through recombinant technology could pave the way for novel diagnostic and therapeutic strategies against diseases where MUCL1 is implicated. Thus, the study of MUCL1 recombinant protein is not merely an academic exercise, but a crucial step toward uncovering new insights into its role in health and disease.
